Trials / Conditions / Relapsing-Remitting
Relapsing-Remitting
5 registered clinical trials studyying Relapsing-Remitting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Efficacy and Safety of Xacrel® (Ocrelizumab) in Participants With Relapsing Remitting Multiple Sclerosis NCT04966338 | Cinnagen | Phase 3 |
| Terminated | Adherence Trial With MS LifeLines ® Services NCT01905527 | EMD Serono | — |
| Completed | A Phase 4 Study to Assess the Impact of Patient Support Program on Health Related Quality of Life and Adherenc NCT01791244 | Merck KGaA, Darmstadt, Germany | Phase 4 |
| Completed | A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720 NCT01578330 | Novartis Pharmaceuticals | Phase 4 |
| Completed | BEYOND Pilot Study NCT00893217 | Bayer | Phase 2 |